Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.
Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.
Sherry L. et al, (2025), NPJ vaccines, 10
TomoCPT: a generalizable model for 3D particle detection and localization in cryo-electron tomograms
Shah PNM. et al, (2025), Acta Crystallographica Section D Structural Biology, 81, 63 - 76
Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines.
Sherry L. et al, (2025), Nature communications, 16
Monkeypox virus isolation from longitudinal samples in 11 hospitalised patients.
Callaby H. et al, (2024), The Lancet. Infectious diseases
Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike.
Duyvesteyn HME. et al, (2024), Structure (London, England : 1993), 32, 1594 - 1602.e6
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in Vietnam
Thanh TT. et al, (2024), International Journal of Infectious Diseases, 147, 107173 - 107173
Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition
(2024), Proceedings of the National Academy of Sciences, 121
The effect of pH on the structure of Bluetongue virus VP5.
Zhang H. et al, (2024), The Journal of general virology, 105
The impact of exchanging the light and heavy chains on the structures of bovine ultralong antibodies
Clarke JD. et al, (2024), Acta Crystallographica Section F Structural Biology Communications, 80, 154 - 163
Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
Pouwels KB. et al, (2024), Nature Communications, 15
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity
Liu C. et al, (2024), Cell Reports Medicine, 5, 101553 - 101553
Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium
Nhu LNT. et al, (2024), Wellcome Open Research, 9, 181 - 181
Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.
Michael BD. et al, (2024), Nature communications, 15
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.
Liu C. et al, (2024), Nature communications, 15
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.
Zhou D. et al, (2024), Nature communications, 15
Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population
Wei J. et al, (2024), Nature Communications, 15
Emerging Enterovirus A71 Subgenogroup B5 Causing Severe Hand, Foot, and Mouth Disease, Vietnam, 2023
Chau NVV. et al, (2024), Emerging Infectious Diseases, 30
From Voxels to Viruses: Using Deep Learning and Crowdsourcing to Understand a Virus Factory
Pennington A. et al, (2024), Citizen Science: Theory and Practice, 9